Bayer's Nexavar meets goal in thyroid cancer trial (Reuters, 3 January 2013)

03 Jan 2013


German firm Bayer have announced positive results from a late-stage trial into Nexavar to treat radioactive iodine refractory differentiated thyroid cancer.

Full article


Share this story